# FDA Inspection 1243316 - Vitalant - June 13, 2024

Source: https://www.globalkeysolutions.net/records/fda_inspections/vitalant/def5db75-2cb7-4cde-8fa1-ac316d66c01f
Source feed: FDA_Inspections

> FDA Inspection 1243316 for Vitalant on June 13, 2024. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1243316
- Company Name: Vitalant
- Inspection Date: 2024-06-13
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1121353 - 2020-03-03](https://www.globalkeysolutions.net/records/fda_inspections/vitalant/709d85c4-b069-4d9f-9147-545c69c88f56)
- [FDA Inspection 1121353 - 2020-03-03](https://www.globalkeysolutions.net/records/fda_inspections/vitalant/00c3ad71-17ef-4541-a529-4b2d10b77d5b)
- [FDA Inspection 1038847 - 2018-01-16](https://www.globalkeysolutions.net/records/fda_inspections/vitalant/ad8bd9be-273d-4382-9653-0e22eb48d67b)
- [FDA Inspection 966878 - 2016-01-11](https://www.globalkeysolutions.net/records/fda_inspections/vitalant/1a9a7f02-6b1d-4aa1-84bd-95699525e553)
- [FDA Inspection 859001 - 2013-12-13](https://www.globalkeysolutions.net/records/fda_inspections/vitalant/277a36e2-c6ba-4d82-a339-0a4dfe8b0a23)

Company: https://www.globalkeysolutions.net/companies/vitalant/3494edfd-75da-43b9-b301-0f08643f8672

Office: https://www.globalkeysolutions.net/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d